Aida Pharmaceuticals Financials
| AIDA Stock | USD 0.0002 0.00 0.00% |
Aida |
Understanding current and past Aida Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Aida Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in Aida Pharmaceuticals' assets may result in an increase in income on the income statement.
Please note, the presentation of Aida Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Aida Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Aida Pharmaceuticals' management manipulating its earnings.
Aida Pharmaceuticals Stock Summary
Aida Pharmaceuticals competes with Assembly Biosciences, Instil Bio, Nuvation Bio, Achilles Therapeutics, and NextCure. Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. Aida Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Hangzhou, China. Aida Pharmaceuticals is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 31 Dingjiang Road, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.aidapharma.com |
| Phone | 86 571 8580 2712 |
| Currency | USD - US Dollar |
Aida Pharmaceuticals Key Financial Ratios
Aida Pharmaceuticals' financial ratios allow both analysts and investors to convert raw data from Aida Pharmaceuticals' financial statements into concise, actionable information that can be used to evaluate the performance of Aida Pharmaceuticals over time and compare it to other companies across industries.| Return On Equity | -0.0179 | |||
| Return On Asset | 0.0662 | |||
| Number Of Employees | 450 | |||
| Beta | 15.94 |
Aida Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Aida Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Aida Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aida Pharmaceuticals competition to find correlations between indicators driving Aida Pharmaceuticals's intrinsic value. More Info.Aida Pharmaceuticals is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Aida Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Aida Pharmaceuticals' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Aida Pharmaceuticals Systematic Risk
Aida Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Aida Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Aida Pharmaceuticals correlated with the market. If Beta is less than 0 Aida Pharmaceuticals generally moves in the opposite direction as compared to the market. If Aida Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Aida Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Aida Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Aida Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
Aida Pharmaceuticals January 31, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Aida Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Aida Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Aida Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Aida Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Aida Pharmaceuticals's daily price indicators and compare them against related drivers.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 33.33 |
Complementary Tools for Aida Pink Sheet analysis
When running Aida Pharmaceuticals' price analysis, check to measure Aida Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aida Pharmaceuticals is operating at the current time. Most of Aida Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aida Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aida Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aida Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |